Yekaterina A. Miroshnikova

Dr. Yekaterina A. Miroshnikova

Stadtman Tenure-Track Investigator, NIDDK/NIH, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
LBLeah C. Biggs
Leah C. Biggs
CKChristine S. Kim
Christine S. Kim
YMYekaterina A. Miroshnikova
Yekaterina A. Miroshnikova
SWSara A. Wickström
Sara A. Wickström

1 August 2018 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
JLJustyna Lisowska
Justyna Lisowska
CRClaudia Jasmin Rödel
Claudia Jasmin Rödel
SMSandra Manet
Sandra Manet
YMYekaterina A. Miroshnikova
Yekaterina A. Miroshnikova
CBCyril Boyault
Cyril Boyault
EFEva Faurobert
Eva Faurobert
Endothelial integrity relies on a mechanical crosstalk between intercellular and cell-matrix interactions. This cross-talk is compromised in hemorrhagic vascular lesions of patients carrying loss-of-function mutations in CCM genes. RhoA/ROCK-dependent cytoskeletal remodeling is central to the disease as it causes unbalanced cell adhesion towards increased cell-extracellular matrix adhesions and destabilized cell-cell junctions. Our study reveals that CCM proteins directly orchestrate ROCK1 and ROCK2 complementary roles on the mechanics of the endothelium. CCM proteins act as a scaffold promoting ROCK2 interactions with VE-cadherin and limiting ROCK1 kinase activity. Loss of CCM1 produces excessive ROCK1-dependent actin stress fibers and destabilizes intercellular junctions. Silencing of ROCK1 but not ROCK2 restores the adhesive and mechanical homeostasis of CCM1/2-depleted endothelial monolayers and rescues cardiovascular defects of ccm1 mutant zebrafish embryos. Conversely, knocking down of Rock2 but not Rock1 in WT zebrafish embryos generates defects reminiscent of the ccm1 mutant phenotypes. Our study uncovers the role of the CCM complex in controlling ROCK1 and ROCK2 to preserve endothelial integrity and drive heart morphogenesis. Moreover, it identifies solely the ROCK1 isoform as therapeutic target for the CCM disease.

8 January 2025 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
SHSolène Hervé
Solène Hervé
ASAndrea Scelfo
Andrea Scelfo
GMGabriele Bersano Marchisio
Gabriele Bersano Marchisio
MGMarine Grison
Marine Grison
KVKotryna Vaidžiulytė
Kotryna Vaidžiulytė
DFDaniele Fachinetti
Daniele Fachinetti
Errors during cell division lead to aneuploidy, which is associated with genomic instability and cell transformation. In response to aneuploidy, cells activate the tumour suppressor p53 to elicit a surveillance mechanism that halts proliferation and promotes senescence. The molecular sensors that trigger this checkpoint are unclear. Here, using a tunable system of chromosome mis-segregation, we show that mitotic errors trigger nuclear deformation, nuclear softening, and lamin and heterochromatin alterations, leading to rapid p53/p21 activation upon mitotic exit in response to changes in nuclear mechanics. We identify mTORC2 and ATR as nuclear deformation sensors upstream of p53/p21 activation. While triggering mitotic arrest, the chromosome mis-segregation-induced alterations of nuclear envelope mechanics provide a fitness advantage for aneuploid cells by promoting nuclear deformation resilience and enhancing pro-invasive capabilities. Collectively, this work identifies a nuclear mechanical checkpoint triggered by altered chromatin organization that probably plays a critical role in cellular transformation and cancer progression.

17 June 2024 in Current Opinion in Structural Biology
Verified
Journal Article
Closed access
RSRebecca K. Stephens
Rebecca K. Stephens
YMYekaterina A. Miroshnikova
Yekaterina A. Miroshnikova

15 March 2023 in Development
Verified
Journal Article
Closed access
PDF file
YMYekaterina A. Miroshnikova
Yekaterina A. Miroshnikova
MSMarta N. Shahbazi
Marta N. Shahbazi
JNJr Jose Negrete
Jr Jose Negrete
KCKevin J. Chalut
Kevin J. Chalut
ASAustin Smith
Austin Smith
The Company of Biologists’ 2022 workshop on ‘Cell State Transitions: Approaches, Experimental Systems and Models’ brought together an international and interdisciplinary team of investigators spanning the fields of cell and developmental biology, stem cell biology, physics, mathematics and engineering to tackle the question of how cells precisely navigate between distinct identities and do so in a dynamic manner. This second edition of the workshop was organized after a successful virtual workshop on the same topic that took place in 2021.

7 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KMKaitlin P. McCreery
Kaitlin P. McCreery
ASAki Stubb
Aki Stubb
RSRebecca Stephens
Rebecca Stephens
NFNadezda A. Fursova
Nadezda A. Fursova
ACAndrew Cook
Andrew Cook
SWSara A. Wickstrom
Sara A. Wickstrom
Acquisition of specific cell shapes and morphologies is a central component of cell fate transitions. Although signaling circuits and gene regulatory networks that regulate pluripotent stem cell differentiation have been intensely studied, how these networks are integrated in space and time with morphological transitions and mechanical deformations to control state transitions remains a fundamental open question. Here, we focus on two distinct models of pluripotency, primed pluripotent stem cells and pre-implantation inner cell mass cells of human embryos to discover that cell fate transitions associate with rapid changes in nuclear shape and volume which collectively alter the nuclear mechanophenotype. Mechanistic studies in human induced pluripotent stem cells further reveal that these phenotypical changes and the associated active fluctuations of the nuclear envelope arise from growth factor signaling-controlled changes in chromatin mechanics and cytoskeletal confinement. These collective mechano-osmotic changes trigger global transcriptional repression and a condensation-prone environment that primes chromatin for a cell fate transition by attenuating repression of differentiation genes. However, while this mechano-osmotic chromatin priming has the potential to accelerate fate transitions and differentiation, sustained biochemical signals are required for robust induction of specific lineages. Our findings uncover a critical mechanochemical feedback mechanism that integrates nuclear mechanics, shape and volume with biochemical signaling and chromatin state to control cell fate transition dynamics.